Cigna expects revenue gains from launches of Humira biosimilars

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MH

Go back to Cigna expects revenue gains from launches of Humira biosimilars

Cigna Corp. (CI) tops earnings, but misses revenue expectations

February 3, 2023 12:09 PM EST

Cigna Corp. (NYSE: CI) reported earnings for its latest quarter before the opening bell Friday, topping earnings but missing revenue consensus expectations.

While the earnings beat was enough to push the company's share price higher at the start of the session, the revenue miss and conservative guidance have weighed on Cigna shares, which are currently down 0.65% on the day.

The managed healthcare and insurance company reported earnings of $4.96 per share on revenue of $45.75 billion, beating... More

Cigna Corp. (CI) tops earnings, but misses revenue expectations

February 3, 2023 12:09 PM EST

Cigna Corp. (NYSE: CI) reported earnings for its latest quarter before the opening bell Friday, topping earnings but missing revenue consensus expectations.

While the earnings beat was enough to push the company's share price higher at the start of the session, the revenue miss and conservative guidance have weighed on Cigna shares, which are currently down 0.65% on the day.

The managed healthcare and insurance company reported earnings of $4.96 per share on revenue of $45.75 billion, beating... More